{
    "organizations": [],
    "uuid": "4ec69cb691f2ace3287082126129ea6c9af8ca10",
    "author": "",
    "url": "https://www.reuters.com/article/brief-partner-therapeutics-acquires-leuk/brief-partner-therapeutics-acquires-leukine-from-sanofi-idUSASB0C3GJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Partner Therapeutics Acquires Leukine From Sanofi",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 05 PM / in 10 minutes BRIEF-Partner Therapeutics Acquires Leukine From Sanofi Reuters Staff \nFeb 1 (Reuters) - Sanofi Sa: * PARTNER THERAPEUTICS (PTX) ACQUIRES LEUKINEÂ® FROM SANOFI \n* PARTNER THERAPEUTICS INC - HAS ACQUIRED GLOBAL RIGHTS TO DEVELOP, MANUFACTURE, AND COMMERCIALIZE LEUKINE (SARGRAMOSTIM) FROM SANOFI \n* PARTNER THERAPEUTICS - IN CONNECTION WITH ACQUISITION OF LEUKINE, PTX WILL ALSO ACQUIRE A DEDICATED MANUFACTURING FACILITY IN LYNNWOOD, WASHINGTON Source text for Eikon:  ",
    "published": "2018-02-01T14:04:00.000+02:00",
    "crawled": "2018-02-01T14:18:14.038+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "therapeutic",
        "acquires",
        "leukine",
        "sanofi",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "sanofi",
        "sa",
        "partner",
        "therapeutic",
        "ptx",
        "acquires",
        "sanofi",
        "partner",
        "therapeutic",
        "inc",
        "acquired",
        "global",
        "right",
        "develop",
        "manufacture",
        "commercialize",
        "leukine",
        "sargramostim",
        "sanofi",
        "partner",
        "therapeutic",
        "connection",
        "acquisition",
        "leukine",
        "ptx",
        "also",
        "acquire",
        "dedicated",
        "manufacturing",
        "facility",
        "lynnwood",
        "washington",
        "source",
        "text",
        "eikon"
    ]
}